drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   

Week of Mon, Jul 16th, 2012

Taro nixes Sun Pharma buyout bid

Taro Pharmaceutical Industries Ltd. has given a thumbs-down to an unsolicited buyout proposal by Sun Pharmaceutical Industries Ltd.

Not Your Mother's supports breast cancer organization

Not Your Mother's hair care plans to donate 10% of all of its online sales during October to the Young Survival Coalition (YSC) in recognition of Breast Cancer Awareness Month.

Dr. Reddy's launches Lipitor generic

Dr. Reddy's Laboratories has shipped atorvastatin calcium tablets, a medication for high cholesterol, in the U.S. market.

Unilever, Cynosure team on facial wrinkle device

Cynosure Inc. has received approval from the Food and Drug Administration for an over-the-counter device, developed with Unilever, to treat facial wrinkles.

VIVUS gets FDA OK for obesity drug

VIVUS Inc. has been cleared by the Food and Drug Administration to market Qsymia, a weight-loss pill aimed at adults struggling with obesity and related health conditions.

Lannett appoints new chairman

Jeffrey Farber, vice chairman at Lannett Co., has been named chairman, succeeding Ronald West.

Karma Wellness Water hits chain store shelves

Karma Culture LLC has made its Karma Wellness Water available at drug store, supermarket and convenience store chains nationwide.

Social media, Web alter dynamics of marketing

The Internet and the burgeoning use of social media will continue to have a significant impact on the marketing efforts of retailers and suppliers, a panel of experts told about 200 people gathered for one the educational sessions at this year’s NACDS Marketplace Conference.

Par Pharma to be sold to TPG

Par Pharmaceutical Cos. has agreed to be acquired by private equity firm TPG in a deal valued at $1.9 billion.

Sanofi Pasteur releases flu vaccine in U.S.

Sanofi Pasteur has begun shipping the first lots of Fluzone vaccine to U.S. health care providers with the Food and Drug Administration's licensing of the 2012-13 formulation.

GSK to buy Human Genome Sciences

GlaxoSmithKline plans to acquire Human Genome Sciences (HGS) in a cash deal of about $3 billion.